Global Organ-on-Chip Market Forecast 2025-2030: Growth at 40% CAGR Expected
Global Organ-on-Chip Market Overview: 2025-2030
Base Year: 2024
Historical Years: 2020-23
Forecast Years: 2025-2030
The Global
Organ-on-Chip Market size was valued at around USD 126 million in
2024 and is projected to reach USD 950 million by 2030. Along
with this, the market is estimated to grow at a CAGR of around 40% during
the forecast period (2025-30).
Our Latest Reports Now Include In-Depth
Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff
Challenges with Greater Agility Get Sample Report – https://www.marknteladvisors.com/query/request-sample/organ-on-chip-market.html
Global Organ-on-Chip Market Dynamics: 2025-2030
Global
Organ-on-Chip Market Driver:
Growing
Demand for Alternatives to Animal Testing in Drug Discovery – The worldwide market for organ-on-chip
technology is driven by the growing need for alternatives to animal testing in
drug discovery. To enhance safety & efficacy evaluations and lessen the
ethical issues surrounding animal testing regulatory organizations like the FDA
and EMA promote the use of sophisticated in-vitro models. The FDA Modernization
Act 2.0. passed by the USA government in the year 2022, will greatly decrease
the use of animal drug testing by promoting the use of substitute techniques
like organ-on-chips. Precise simulation of human organ function through systems
such as the liver and lung on chips offers increased predictive accuracy of
drug toxicity and metabolism studies. For instance; Emulate's liver on a chip
has been widely utilized to predict hepatotoxicity in candidates for drugs
reducing dependence on animal models. This shows how Organ-On-Chip technology
is changing the scenario of preclinical testing to provide ethical and cost-effective
solutions for the pharmaceutical industry with alternatives to animal
testing.
Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/organ-on-chip-market.html
Global Organ-on-Chip Market (2025-30):
Segmentation Outlook
The market
report has segmented the market into the following categories:
By Model Type
-Organ-Based
Model- Market Size & Forecast 2020-2030, USD Million
-Disease-Based
Model- Market Size & Forecast 2020-2030, USD Million
-By Material
-Polydimethylsiloxane
(PDMS)- Market Size & Forecast 2020-2030, USD Million
-Polymer- Market
Size & Forecast 2020-2030, USD Million
-Glass- Market
Size & Forecast 2020-2030, USD Million
By Solution
-Products-
Market Size & Forecast 2020-2030, USD Million
-Instruments-
Market Size & Forecast 2020-2030, USD Million
-Consumables
& Accessories - Market Size & Forecast 2020-2030, USD Million
-Software-
Market Size & Forecast 2020-2030, USD Million
-Services-
Market Size & Forecast 2020-2030, USD Million
-Custom
Services- Market Size & Forecast 2020-2030, USD Million
-Standard
Services- Market Size & Forecast 2020-2030, USD Million
By Organ Type
-Liver-Market
Size & Forecast 2020-2030, USD Million
-Intestine-Market
Size & Forecast 2020-2030, USD Million
-Kidney-Market
Size & Forecast 2020-2030, USD Million
-Lung-Market
Size & Forecast 2020-2030, USD Million
-Heart-Market
Size & Forecast 2020-2030, USD Million
-Other organs
Based on organ type, the Liver segment
leads the global market. It holds approx. 30% of the total market value.
By Application
-Toxicology
Research-Market Size & Forecast 2020-2030, USD Million
-Drug
Discovery-Market Size & Forecast 2020-2030, USD Million
-Physiological
Model Development-Market Size & Forecast 2020-2030, USD Million
-Stem cell
Research-Market Size & Forecast 2020-2030, USD Million
-Tissue
regeneration and regenerative Medicines-Market Size & Forecast 2020-2030,
USD Million
-Others
By End User
-Pharmaceutical
and Biotechnology Companies-Market Size & Forecast 2020-2030, USD Million
-Cosmetics
Industry-Market Size & Forecast 2020-2030, USD Million
-Academic and
Research Institutes-Market Size & Forecast 2020-2030, USD Million
-Others
By Region
-North America
-South America
-Europe
-The Middle East
& Africa
-Asia-Pacific.
Out of them, North America dominates the
Global Organ-on-Chip Market. It holds approx. 52% market share.
Note - If there are any particular
details you need that are not currently included in the report, we will be
happy to provide them as part of our customization
services.
Top Companies Operating in the Global
Organ-on-Chip Market:
Altis Biosystems,
AlveoliX AG, Axosim, Bi/ond Solutions B.V, Cherry Biotech, CN-Bio, Emulate,
Inc., Hesperos, Inc., Insphero, MesoBioTech, Mimetas B.V., Nortis Inc.,
React4Life, TARA Biosystems (Valo Health), TissUse GmbH and Others.
Industry Recent
Development:
- April 2024: CN Bio secured USD
21 million in Series B funding from Bayland Capital and CN Innovations
Holdings Ltd. to expand its product development & scaling, meeting the
rising demand for organ on a chip solution and driven by improved drug R&D
efficiency and legislative changes like the US FDA Modernization Act 2.0.
- March 2024: MIMETAS joined the
Centre for Animal-Free Biomedical Translation (CPBT), which received
USD134.78 million from the Dutch National Growth Fund to advance
animal-free biomedical innovations.
Reports Delivery
Format - Market research studies from MarkNtel Advisors are offered in PDF,
Excel, and PowerPoint formats. Within 24 hours of the payment being
successfully received, the report will be sent to your email address
About Us –
We are a leading
market research company, consulting, & data analytics firm that provides an
extensive range of strategic reports on diverse industry verticals. We deliver
data to a substantial & varied client base, including multinational
corporations, financial institutions, governments, & individuals, among
others.
Our
specialization in niche industries & emerging geographies allows our
clients to formulate their strategies in a much more informed way and entail
parameters like Go-to-Market (GTM), product development, feasibility analysis,
project scoping, market segmentation, competitive benchmarking, market sizing
& forecasting, & trend analysis, among others, for 15 diverse
industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office:
564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301,
India
Comments
Post a Comment